Vermont docs got $2.9 million from drugmakers in '08 Drug companies spent $2.9 million on payments to health care professionals, hospitals, universities and clinics in Vermont last year, according to a report released by the Vermont Attorney General’s off

Hopkins bans gifts, drug samples Johns Hopkins has banned some types of gifts, meals and drug samples from pharmaceutical companies, says the WSJ HealthBlog. The policy, which extends not only to the University's medical school but also to its affiliated

One click is too far to go for risk information, according to a series of warning letters the FDA sent to drug manufacturers last Friday. The fourteen letters pointed out violations in online search engine ads for over 45 drugs made by some of the nation’

Stanford will put researchers’ industry payments online Stanford has announced it will disclose the names of researchers and faculty members who receive drug and device company consulting payments on a public website beginning later this year. The move ma

Help reverse the medical device "tort reform" by the Supreme Court that has left thousands of injured patients without the right to sue, and puts many more patients at risk!  The following announcement and open letter to Congress was organized by the Camp

The American Psychiatric Association has voted to end industry-funded CME offerings at its annual meeting, as well as to phase out meals from drug companies. The industry-sponsored symposia netted up to $1.5 million per year for the association, which is

The American Medical Association seems to have taken a report recommending the end of industry funding of Continuing Medical Education (CME) off its website.  The recommendations, brought before the AMA's Reference Committee on Amendments to Constitution

PAL's most important lawsuit and settlement to date wins final approval! Yesterday, the Massachusetts federal District Court approved class action settlements with publishers First Databank and MediSpan that will require the roll back the illegally inflat

Massachusetts reached a significant milestone today in the effort to both measure and manage the extent of pharmaceutical and medical device marketing to prescribers.  The state's Public Health Council today passed strong regulations that limit gifts and